vs

Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and SOUNDTHINKING, INC. (SSTI). Click either name above to swap in a different company.

SOUNDTHINKING, INC. is the larger business by last-quarter revenue ($24.8M vs $13.8M, roughly 1.8× FENNEC PHARMACEUTICALS INC.). SOUNDTHINKING, INC. runs the higher net margin — -11.2% vs -34.7%, a 23.6% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 5.9%). Over the past eight quarters, SOUNDTHINKING, INC.'s revenue compounded faster (-1.2% CAGR vs -26.3%).

Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.

SoundThinking, Inc. is a public safety technology provider specializing in acoustic monitoring solutions, most notably gunshot detection systems. It delivers data-driven tools and analytics services to law enforcement agencies, municipal governments and public safety organizations primarily across North America, helping improve emergency response efficiency and community safety outcomes.

FENC vs SSTI — Head-to-Head

Bigger by revenue
SSTI
SSTI
1.8× larger
SSTI
$24.8M
$13.8M
FENC
Growing faster (revenue YoY)
FENC
FENC
+68.0% gap
FENC
73.8%
5.9%
SSTI
Higher net margin
SSTI
SSTI
23.6% more per $
SSTI
-11.2%
-34.7%
FENC
Faster 2-yr revenue CAGR
SSTI
SSTI
Annualised
SSTI
-1.2%
-26.3%
FENC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FENC
FENC
SSTI
SSTI
Revenue
$13.8M
$24.8M
Net Profit
$-4.8M
$-2.8M
Gross Margin
50.9%
Operating Margin
-18.5%
-10.2%
Net Margin
-34.7%
-11.2%
Revenue YoY
73.8%
5.9%
Net Profit YoY
-141.1%
32.0%
EPS (diluted)
$-0.17
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FENC
FENC
SSTI
SSTI
Q4 25
$13.8M
$24.8M
Q3 25
$12.5M
$25.1M
Q2 25
$9.7M
$25.9M
Q1 25
$8.8M
$28.3M
Q4 24
$7.9M
$23.4M
Q3 24
$7.0M
$26.3M
Q2 24
$7.3M
$27.0M
Q1 24
$25.4M
$25.4M
Net Profit
FENC
FENC
SSTI
SSTI
Q4 25
$-4.8M
$-2.8M
Q3 25
$-638.0K
$-2.0M
Q2 25
$-3.2M
$-3.1M
Q1 25
$-1.2M
$-1.5M
Q4 24
$-2.0M
$-4.1M
Q3 24
$-5.7M
$-1.4M
Q2 24
$-5.6M
$-752.0K
Q1 24
$12.8M
$-2.9M
Gross Margin
FENC
FENC
SSTI
SSTI
Q4 25
50.9%
Q3 25
54.3%
Q2 25
53.3%
Q1 25
58.5%
Q4 24
50.0%
Q3 24
58.0%
Q2 24
59.6%
Q1 24
58.6%
Operating Margin
FENC
FENC
SSTI
SSTI
Q4 25
-18.5%
-10.2%
Q3 25
-1.5%
-8.2%
Q2 25
-28.3%
-11.4%
Q1 25
-9.2%
-4.2%
Q4 24
-11.8%
-17.7%
Q3 24
-74.6%
-4.0%
Q2 24
-69.4%
-0.2%
Q1 24
54.2%
-10.3%
Net Margin
FENC
FENC
SSTI
SSTI
Q4 25
-34.7%
-11.2%
Q3 25
-5.1%
-8.1%
Q2 25
-32.7%
-12.1%
Q1 25
-13.3%
-5.2%
Q4 24
-25.0%
-17.4%
Q3 24
-82.2%
-5.5%
Q2 24
-76.5%
-2.8%
Q1 24
50.6%
-11.4%
EPS (diluted)
FENC
FENC
SSTI
SSTI
Q4 25
$-0.17
$-0.22
Q3 25
$-0.02
$-0.16
Q2 25
$-0.11
$-0.24
Q1 25
$-0.04
$-0.12
Q4 24
$-0.02
$-0.32
Q3 24
$-0.21
$-0.11
Q2 24
$-0.20
$-0.06
Q1 24
$0.41
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FENC
FENC
SSTI
SSTI
Cash + ST InvestmentsLiquidity on hand
$36.8M
$15.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$35.5M
$72.2M
Total Assets
$70.6M
$135.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FENC
FENC
SSTI
SSTI
Q4 25
$36.8M
$15.8M
Q3 25
$21.9M
$11.8M
Q2 25
$18.7M
$8.9M
Q1 25
$22.7M
$11.7M
Q4 24
$26.6M
$13.2M
Q3 24
$40.3M
$15.3M
Q2 24
$43.1M
$9.8M
Q1 24
$51.2M
$8.5M
Total Debt
FENC
FENC
SSTI
SSTI
Q4 25
Q3 25
$19.4M
Q2 25
$19.4M
Q1 25
$19.4M
Q4 24
$19.3M
Q3 24
$32.1M
Q2 24
$31.8M
Q1 24
$31.3M
Stockholders' Equity
FENC
FENC
SSTI
SSTI
Q4 25
$35.5M
$72.2M
Q3 25
$-4.5M
$73.5M
Q2 25
$-7.5M
$74.5M
Q1 25
$-5.9M
$73.8M
Q4 24
$-5.9M
$72.4M
Q3 24
$-5.2M
$73.3M
Q2 24
$-1.4M
$75.6M
Q1 24
$3.0M
$74.8M
Total Assets
FENC
FENC
SSTI
SSTI
Q4 25
$70.6M
$135.8M
Q3 25
$49.3M
$134.4M
Q2 25
$44.9M
$134.8M
Q1 25
$46.4M
$136.3M
Q4 24
$44.9M
$136.8M
Q3 24
$58.9M
$141.7M
Q2 24
$63.2M
$145.9M
Q1 24
$69.2M
$145.0M
Debt / Equity
FENC
FENC
SSTI
SSTI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
10.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FENC
FENC
SSTI
SSTI
Operating Cash FlowLast quarter
$-6.0M
$4.5M
Free Cash FlowOCF − Capex
$3.7M
FCF MarginFCF / Revenue
14.9%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FENC
FENC
SSTI
SSTI
Q4 25
$-6.0M
$4.5M
Q3 25
$1.5M
$6.2M
Q2 25
$-3.7M
$-1.3M
Q1 25
$-4.3M
$-141.0K
Q4 24
$-1.5M
$-859.0K
Q3 24
$-2.2M
$13.7M
Q2 24
$-8.4M
$4.4M
Q1 24
$39.0M
$5.0M
Free Cash Flow
FENC
FENC
SSTI
SSTI
Q4 25
$3.7M
Q3 25
$4.9M
Q2 25
$-2.7M
Q1 25
$-1.0M
Q4 24
$-2.2M
Q3 24
$12.4M
Q2 24
$2.8M
Q1 24
$2.8M
FCF Margin
FENC
FENC
SSTI
SSTI
Q4 25
14.9%
Q3 25
19.4%
Q2 25
-10.3%
Q1 25
-3.7%
Q4 24
-9.5%
Q3 24
47.4%
Q2 24
10.5%
Q1 24
11.2%
Capex Intensity
FENC
FENC
SSTI
SSTI
Q4 25
3.2%
Q3 25
5.5%
Q2 25
5.3%
Q1 25
3.2%
Q4 24
5.8%
Q3 24
4.7%
Q2 24
5.9%
Q1 24
8.4%
Cash Conversion
FENC
FENC
SSTI
SSTI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
3.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons